1. Home
  2. ATHM vs IMNM Comparison

ATHM vs IMNM Comparison

Compare ATHM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

N/A

Current Price

$19.30

Market Cap

2.5B

Sector

Technology

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$21.42

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATHM
IMNM
Founded
2008
2006
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
ATHM
IMNM
Price
$19.30
$21.42
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$28.00
$32.80
AVG Volume (30 Days)
577.8K
931.8K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
9.11%
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
$5.67
$18.41
Revenue Next Year
$2.17
$863.23
P/E Ratio
$12.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.87
$5.15
52 Week High
$30.19
$27.65

Technical Indicators

Market Signals
Indicator
ATHM
IMNM
Relative Strength Index (RSI) 39.22 45.76
Support Level N/A $18.98
Resistance Level $23.96 $22.57
Average True Range (ATR) 0.68 1.07
MACD 0.04 -0.09
Stochastic Oscillator 41.02 51.38

Price Performance

Historical Comparison
ATHM
IMNM

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: